MATHEW MOLINA: Open Payments
NPI 1134809734 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,223 in 105 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,041 · 2025 $2,223
Food & beverage: $2,204Education: $19
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 30 | $489 |
| ABBVIE INC. | 14 | $370 |
| AstraZeneca Pharmaceuticals LP | 13 | $308 |
| UCB, Inc. | 8 | $223 |
| GlaxoSmithKline, LLC. | 12 | $213 |
| Novartis Pharmaceuticals Corporation | 8 | $175 |
| Radius Health, Inc. | 6 | $141 |
| E.R. Squibb & Sons, L.L.C. | 4 | $99 |
| Janssen Biotech, Inc. | 4 | $74 |
| PFIZER INC. | 3 | $67 |
Products named: SAPHNELO, SKYRIZI, Bimzelx, BENLYSTA, KRYSTEXXA, COSENTYX, Tymlos, RINVOQ.
Industry payments across TX — which companies pay providers there.
